A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Omnicell, Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 27,000 shares of OMCL stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,000
Previous 16,500 63.64%
Holding current value
$1.23 Million
Previous $446,000 163.9%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$25.61 - $45.43 $2.28 Million - $4.05 Million
-89,056 Reduced 22.86%
300,582 $13.1 Million
Q2 2024

Aug 14, 2024

SELL
$26.22 - $32.65 $617,638 - $769,103
-23,556 Reduced 5.7%
389,638 $10.5 Million
Q1 2024

May 15, 2024

BUY
$26.15 - $37.33 $9.62 Million - $13.7 Million
367,713 Added 808.5%
413,194 $12.1 Million
Q4 2023

Feb 14, 2024

BUY
$29.24 - $45.81 $1.33 Million - $2.08 Million
45,481 New
45,481 $1.71 Million
Q2 2023

Aug 14, 2023

BUY
$57.88 - $75.94 $5.2 Million - $6.83 Million
89,896 Added 149.5%
150,028 $11.1 Million
Q1 2023

May 15, 2023

BUY
$51.51 - $60.43 $1.31 Million - $1.53 Million
25,392 Added 73.09%
60,132 $3.53 Million
Q4 2022

Feb 14, 2023

SELL
$46.24 - $90.03 $14.4 Million - $28.1 Million
-312,179 Reduced 89.99%
34,740 $1.75 Million
Q3 2022

Nov 14, 2022

BUY
$84.23 - $117.38 $29.2 Million - $40.7 Million
346,919 New
346,919 $30.2 Million
Q1 2022

May 16, 2022

SELL
$120.68 - $180.51 $4.87 Million - $7.29 Million
-40,370 Reduced 61.7%
25,064 $3.25 Million
Q4 2021

Feb 14, 2022

SELL
$153.26 - $183.62 $2.59 Million - $3.1 Million
-16,872 Reduced 20.5%
65,434 $11.8 Million
Q3 2021

Nov 15, 2021

BUY
$141.84 - $160.88 $3.48 Million - $3.95 Million
24,526 Added 42.45%
82,306 $12.2 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $151.45 $4.96 Million - $5.79 Million
38,210 Added 195.25%
57,780 $8.75 Million
Q1 2021

May 17, 2021

SELL
$117.78 - $143.9 $3.21 Million - $3.92 Million
-27,219 Reduced 58.17%
19,570 $2.54 Million
Q4 2020

Feb 16, 2021

SELL
$73.85 - $120.02 $5.25 Million - $8.53 Million
-71,112 Reduced 60.32%
46,789 $5.62 Million
Q1 2020

May 15, 2020

BUY
$55.41 - $90.19 $1.8 Million - $2.93 Million
32,437 Added 37.95%
117,901 $7.73 Million
Q4 2019

Feb 14, 2020

BUY
$70.15 - $83.11 $218,166 - $258,472
3,110 Added 3.78%
85,464 $6.99 Million
Q3 2019

Nov 14, 2019

BUY
$68.36 - $88.34 $3.6 Million - $4.65 Million
52,594 Added 176.73%
82,354 $5.95 Million
Q2 2019

Aug 14, 2019

SELL
$71.38 - $92.21 $39,330 - $50,807
-551 Reduced 1.82%
29,760 $2.56 Million
Q1 2019

May 15, 2019

SELL
$58.88 - $86.19 $9.14 Million - $13.4 Million
-155,242 Reduced 83.66%
30,311 $0
Q4 2018

Feb 14, 2019

BUY
$56.97 - $77.23 $9.31 Million - $12.6 Million
163,342 Added 735.41%
185,553 $11.4 Million
Q2 2018

Aug 10, 2018

BUY
$42.2 - $53.05 $937,304 - $1.18 Million
22,211 New
22,211 $0

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $2.02B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.